Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression

gan Wang, Chuying, Bai, Feng, Zhang, Li-han, Scott, Alexandria, Li, Enxiao, Pei, Xin-Hai
Cyhoeddwyd yn Breast Cancer Res (2018)

Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer...

gan Fan, Yangwei, Ma, Ke, Jing, Jiayu, Wang, Chuying, Hu, Yuan, Shi, Yu, Li, Enxiao, Geng, Qianqian
Cyhoeddwyd yn J Cancer (2020)

HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma

gan YANG, HAIXIA, ZHOU, JIUPENG, MI, JIANQIANG, MA, KE, FAN, YANGWEI, NING, JING, WANG, CHUYING, WEI, XIN, ZHAO, HUADONG, LI, ENXIAO
Cyhoeddwyd yn Oncol Rep (2015)

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors

gan Fan, Yangwei, Ma, Ke, Wang, Chuying, Ning, Jing, Hu, Yuan, Dong, Danfeng, Dong, Xuyuan, Geng, Qianqian, Li, Enxiao, Wu, Yinying
Cyhoeddwyd yn Onco Targets Ther (2016)

α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades

gan Shi, Yu, Fan, Yangwei, Hu, Yuan, Jing, Jiayu, Wang, Chuying, Wu, Yinying, Geng, Qianqian, Dong, Xuyuan, Li, Enxiao, Dong, Danfeng
Cyhoeddwyd yn J Cell Mol Med (2019)

MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer

gan Ma, Ke, Fan, Yangwei, Dong, Xuyuan, Dong, Danfeng, Guo, Yuyan, Wei, Xin, Ning, Jing, Geng, Qianqian, Wang, Chuying, Hu, Yuan, Li, Mengya, Niu, Wenxia, Li, Enxiao, Wu, Yinying
Cyhoeddwyd yn Oncotarget (2017)

PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors

gan Bai, Feng, Liu, Shiqin, Liu, Xiong, Hollern, Daniel P., Scott, Alexandria, Wang, Chuying, Zhang, Lihan, Fan, Cheng, Fu, Li, Perou, Charles M., Zhu, Wei-Guo, Pei, Xin-Hai
Cyhoeddwyd yn Breast Cancer Res (2021)